Searched over 200M research papers
9 papers analyzed
These studies suggest anemia is associated with increased heart rate and adverse cardiac outcomes, including higher mortality and hospitalization rates, particularly in heart failure and coronary heart disease patients.
20 papers analyzed
Anemia has been linked to low heart rate variability (HRV) in patients with coronary heart disease (CHD). A study involving 874 outpatients with stable CHD found that those with anemia (hemoglobin ≤12 g/dl) had significantly lower HRV compared to non-anemic patients. Specifically, 29% to 41% of anemic participants had low HRV, defined as the lowest quartile of each HRV index, compared to 23% to 25% of non-anemic participants. This association persisted even after adjusting for confounding factors such as ischemia and left ventricular function, suggesting that anemia could contribute to increased cardiac risk through its impact on HRV.
In healthy individuals, heart rate increases linearly in response to acute isovolemic anemia. This finding contrasts with earlier studies on anesthetized humans, which reported no change or a decrease in heart rate. The increase in heart rate during acute anemia highlights the body's compensatory mechanism to maintain oxygen delivery despite reduced hemoglobin levels.
Anemia is a common comorbidity in patients with chronic heart failure (CHF) and is associated with increased mortality. A systematic review and meta-analysis of 34 studies involving 153,180 CHF patients found that anemic patients had a significantly higher mortality rate (46.8%) compared to non-anemic patients (29.5%). Lower baseline hemoglobin levels were correlated with higher mortality rates, underscoring the prognostic significance of anemia in CHF .
In diabetic patients, anemia is a significant risk factor for adverse cardiovascular outcomes, particularly in those with chronic kidney disease (CKD). A study pooling data from four community-based cohorts found that anemia increased the risk of myocardial infarction, fatal coronary heart disease, stroke, and all-cause mortality in patients with CKD. However, anemia did not pose a significant risk for these outcomes in diabetic patients without CKD, indicating that the presence of CKD modifies the impact of anemia on cardiovascular risk.
Anemia in heart failure patients is associated with worse clinical outcomes, including higher rates of hospitalization and mortality. A meta-analysis of studies from the last decade confirmed that anemia significantly increases the risk of both mortality and hospitalization in heart failure patients. This finding supports the need for careful management of anemia in this population to improve prognostic outcomes .
Anemia is prevalent among patients undergoing percutaneous coronary intervention (PCI) and is linked to higher risks of mortality, major adverse cardiovascular events (MACE), myocardial infarction, and bleeding. A meta-analysis of 44 studies with 230,795 participants revealed that anemic patients had a significantly higher risk of adverse outcomes compared to non-anemic patients. This underscores the importance of addressing anemia in patients undergoing PCI to mitigate these risks.
The relationship between anemia and heart rate, as well as its broader cardiovascular implications, is well-documented across various patient populations. Anemia is associated with lower heart rate variability in coronary heart disease, increased heart rate in acute isovolemic anemia, and higher mortality and hospitalization rates in heart failure and PCI patients. These findings highlight the critical need for effective management of anemia to improve cardiovascular outcomes.
Most relevant research papers on this topic